Abstract:We read with great interest the study by Yeh et al.1 on hepatitis B virus (HBV)-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predicting postoperative survival in hepatocellular carcinoma (HCC). According to the article, the amount of HBV-DNA in liver tissue and the presence of the basal core promoter mutation were two independent predictors for postoperative survival in HCC. The authors also found that a short-stretch pre-S deletion located between codons 107 and 141 was associated with a poorer postoperative prognosis. This study can be hailed as an original contribution in terms of predicting postoperative survival in HCC; however, we have some concerns about it. First, as is well known, evidence suggests that HBV genetic mutations contribute to the risk of HCC. Recent studies have shown that HBV genotype- or subgenotype-specific mutations, including C1653T in the EnhII region, T1753V, and the double mutant A1762T/G1764A in the BCP region, are independent risk factors for HCC.2 Another study has indicated that pre-S deletions, I68T in surface gene, T1762/A1764, and A1899 are independent risk factors for HCC.3 A recent meta-analysis revealed that the HBV pre-S mutations C1653T, T1753V, and A1762T/G1764A are associated with an increased risk of HCC. These mutations alone and in combination may be predictive of hepatocarcinogenesis.4 We wonder whether the other gene mutations correlated with HCC in HBV other than the basal core promoter A1762T/G1764A mutation (e.g., C1653T, T1753V, A1899) can independently predict postoperative survival in HCC. Second, it has not been determined whether hepatitis B e antigen (HBeAg) is associated with postresection survival in HCC. According to Sun et al.,5 HBeAg was associated with a higher risk of early recurrence and poorer survival in patients after curative resection of small HCC. However, Chen et al.3 indicated that HBeAg positivity is not a negative factor for resection in HCC patients and has no significant influence on postresection survival. Therefore, we wonder whether HBeAg was associated with postresection survival in HCC in the study by Yeh et al. Given that the serum samples used in the study had been stored in the serum bank, we think that the detection of HBeAg in both groups is convenient and has great significance. Finally, a study by Tomimaru et al.6 showed that histological assessment of the degree of fibrosis in noncancerous tissue is a unique prognostic factor for primary HCC without hepatitis B or C viral infection. If this is the case, then is histological assessment of the degree of fibrosis in noncancerous tissue one of the prognostic factors for HBV-related HCC as well?

Baseline HBV-DNA load plus AST/ALT ratio predicts prognosis of HBV-related hepatocellular carcinoma after hepatectomy: A multicentre study

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy.

HBV is a Risk Factor for Poor Patient Prognosis after Curative Resection of Hepatocellular Carcinoma

Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy

High Viral Load is Associated with Poor Overall and Recurrence-Free Survival of Hepatitis B Virus-Related Hepatocellular Carcinoma after Curative Resection: A Prospective Cohort Study

Prognostic Value of ALT, AST, and AAR in Hepatocellular Carcinoma with B-Type Hepatitis-Associated Cirrhosis after Radical Hepatectomy.

[Effect of HBV DNA load on the safety and prognosis of systematic therapy in advanced hepatocellular carcinoma]

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

Predictive Effects of Preoperative Serum CA125 and AFP Levels on Post-Hepatectomy Survival in Patients with Hepatitis B-related Hepatocellular Carcinoma

Hepatitis B Virus Dna Level Predicts Poor Outcomes In Hepatocellular Carcinoma Patients

Distinguished Prognosis of Hepatocellular Carcinoma with or Without Cirrhosis: A Long-term Follow-up Analysis

Impact of baseline hepatitis B virus viral load on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy

Are There More Factors Other Than Hepatitis B Virus DNA Level and A1762T/G1764A Mutation in Liver Tissue That Also Independently Predict Postoperative Survival in Hepatocellular Carcinoma?

Factors Predicting Occurrence and Prognosis of Hepatitis-B-virus-related Hepatocellular Carcinoma

HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion.

Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients.

Abstract 716: High Viral Load is Associated with Poor Postoperative Survival in Hepatitis B Virus-Related Hepatocellular Carcinoma

The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis

The association between ratio index of gamma glutamyl transpeptidase/platelet and the prognosis of patients with hepatitis B virus related hepatocellular carcinoma before liver resection

Post-transplant HBV reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-center retrospective cohort study in China